SHAREHOLDERS' EQUITY (Details) - shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Class of Stock [Line Items] | ||
| Shares available for future grants under the 2021 plan | 10,871,688 | 8,941,243 |
| Shares available for future grants under the 2024 Foundation plan | 14,410 | 15,000 |
| Shares subject to the employee share purchase plan | 1,118,576 | 1,156,437 |
| Total | 66,589,078 | 64,050,412 |
| Ordinary shares | ||
| Class of Stock [Line Items] | ||
| Ordinary shares reserved for future issuance | 51,551,462 | 50,773,337 |
| Outstanding share options and RSUs | ||
| Class of Stock [Line Items] | ||
| Ordinary shares reserved for future issuance | 3,032,942 | 3,164,395 |
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. No definition available.
|
| X | ||||||||||
- Definition Represents shares available for future issuance. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The highest quantity of shares an employee can purchase under the plan per period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|